moxisylyte has been researched along with Incontinentia Pigmenti Achromians in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haynes, WL | 1 |
| Johnson, AT | 1 |
| Alward, WL | 1 |
1 other study available for moxisylyte and Incontinentia Pigmenti Achromians
| Article | Year |
|---|---|
Inhibition of exercise-induced pigment dispersion in a patient with the pigmentary dispersion syndrome.
Topics: Adult; Humans; Intraocular Pressure; Iris; Male; Moxisylyte; Physical Exertion; Pigment Epithelium o | 1990 |